Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-blind, Placebo and Active-controlled Efficacy and Safety Study of SSR240600C in Patients With Overactive Bladder (OAB) or Urge Urinary Incontinence (UUI)

NCT00174798 is registered in ClinicalTrials.gov with Sanofi as lead sponsor.

NCT NCT00174798
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00174798 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-blind, Placebo and Active-controlled Efficacy and Safety Study of SSR240600C in Patients With Overactive Bladder (OAB) or Urge Urinary Incontinence (UUI)
Lead sponsor
Sanofi
Phase
Phase 2
Overall status
Completed
Start date
May 31, 2005
Completion date
May 31, 2006
Enrollment
118 (actual)
Sites
22

Conditions

As the registry lists them; a condition with its own page is linked.

overactive bladder